12. Earnings per share | | | | | | | | | | | | Year ended December 31, | | | 2025 | | 2024 | | 2023 | | | | | | | | | | | Net profit attributable to owners of the parent (Euro, in thousands) | | € | 320,884 | | € | 74,082 | | € | 211,697 | Number of shares (thousands) | | | | | | | | | | Weighted average number of shares for the purpose of basic earnings/loss (-) per share | | | 65,897 | | | 65,897 | | | 65,884 | Basic earnings per share (Euros) | | € | 4.87 | | € | 1.12 | | € | 3.21 | | | | | | | | | | | Net profit attributable to owners of the parent (Euro, in thousands) | | € | 320,884 | | € | 74,082 | | € | 211,697 | Number of shares (thousands) | | | | | | | | | | Weighted average number of shares for the purpose of diluted earnings/loss (-) per share | | | 65,897 | | | 65,897 | | | 65,884 | Number of dilutive potential ordinary shares | | | 4 | | | 45 | | | 49 | Diluted earnings per share (Euros) | | € | 4.87 | | € | 1.12 | | € | 3.21 |
Reference is also made to note 2 where an explanation is provided about the terms and conditions of the outstanding subsequent Warrant B that can, potentially, be exercised by Gilead and lead to a dilutive effect. Due to the exercise price mechanism of the Gilead subsequent Warrant B, this warrant was out-of-the-money for all years presented.
|